Regression of acquired immunodeficiency syndrome-related pulmonary kaposps sarcoma after highly active antiretroviral therapy

Mayo Clinic Proceedings

Volumn 73, Issue 5, 1998, Pages 439-443

  Aboulafia, David M ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CLARITHROMYCIN; COTRIMOXAZOLE; FLUCONAZOLE; INDINAVIR; LAMIVUDINE; STAVUDINE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; KAPOSI SARCOMA; LUNG SARCOMA; LYMPHOCYTE COUNT; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PNEUMOCYSTIS PNEUMONIA; TUMOR REGRESSION;

EID: 0031748252     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)63726-9     Document Type: Article

References (41)

1. Biggar RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 1996 Oct; 10:997-1010
2. Miller G, Rigsby MO, Heston L, Grogan E, Sun R, Metroka C, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N EnglJ Med 1996;334:1292-1297
3. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-924
4. Mitchell DM, McCarty M, Fleming J, Moss FM. Bronchopulmonary Kaposi's sarcoma in patients with AIDS. Thorax 1992;47:726-729
5. Gruden JF, Huang L, Webb WR, Gamsu G, Hopewell PC, Sides DM. AIDS-related Kaposi sarcoma of the lung: radiographie findings and staging system with bronchoscopic correlation. Radiology 1995; 195:545-552
6. Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, et al. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med 1991;90:427-433
7. Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, et al (AIDS Clinical Trials Group). Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N EnglJ Med 1996;334:1011-1017
8. Gulick R, Mellors J, Havlir D, Eron J, Gonzalez C, McMahon D, et al. Potent and sustained antiretroviral activity of indinavir (IDV) in combi-
9. nation with zidovudine (ZDV) and lamivudine (3TC) [abstract]. 3rd Conf Retroviruses Opportun Infect 1996;3:162
10. Whitcup SM, Fortin E, Nussenblatt RB, Polis MA, Muccioli C, Belfort R Jr. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis [letter]. JAMA 1997;277:1519-1520
11. Power C, Nath A, Aoki FY, Bigio MD. Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection [letter]. N Engl J Med 1997;336:661-662
12. Elliot B, Aromin I, Gold R, Flanigan T, Mileno M. 2.5 Year remis sion of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy [letter]. Lancet 1997;349: 850
13. Carr A, Foudraine N, Reiss P, Marriott D, Lange J, Cooper D, et al. Resolution of antibiotic-resistant cryptosporidiosis (C) and microsporidiosis (M) with potent combination antiretroviral therapy [abstract]. 4th Conf Retroviruses Opportun Infect 1997;4: 191
14. Volm MD, Wernz J. Patients with advanced AIDS-related Kaposi's sarcoma (EKS) no longer require systemic therapy after introduction of effective antiretroviral therapy [abstract]. Proc Annu Meet Am Soc Clin Oncol 1997;16:A162
15. Klein MB, Pereira FA, Kantor I. Kaposi sarcoma complicating systemic lupus erythematosus treated with immunosuppression. Arch Dermatol 1974; 110:602-604
16. Casoli P, Tumiati B. Rheumatoid arthritis, corticosteroid therapy and Kaposi's sarcoma: a coincidence? A case and review of literature. Clin Rheumatol 1992;ll:432-435
17. Hiesse C, Larue JR, Kriaa F, Blanchet P, Bellamy J, Benoit G, et al. Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: singlecenter analysis of a 20-year period in 1600 patients. Transplant Proc 1995:27:2450-2451
18. Carmeli Y, Mevorach D, Kaminski N, Raz E. Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis. Cancer 1994;73:2859-2861
19. Safai B. Kaposi's sarcoma and acquired immunodeficiency syndrome. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. AIDS: Etiology, Diagnosis, Treatment and Prevention. 4th ed. Philadelphia: Lippincott-Raven; 1997. pp 295-317
20. Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989:243:223226
21. Miles SA. Pathogenesis of AIDS-related Kaposi's sarcoma: evidence of a viral etiology. Hematol Oncol Clin North Am 1996 Oct;10:10111021
22. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeid M, et al. Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma. Nature 1994:371:674680
23. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 1995:95:1723-1734
24. Harrington WJ Jr, Sieczkowski L, Sosa C, Chan-a-Sue S, Cai JP, Cabrai L, et al. Activation of HHV-8 by HIV-1 tat [letter]. Lancet 1997; 349:774-775
25. Real FX, Krown SE. Spontaneous regression of Kaposi's sarcoma in patients with AIDS [letter]. N EngU Med 1985:313:1659
26. Langford A, Ruf B, Kunze R, Pohle HD, Reichart P. Regression of oral Kaposi's sarcoma in a case of AIDS on zidovudine (AZT). BrJ Dermatol 1989:120:709-713
27. Kovacs JA, Deyton L, Davey R, Falloon J, Zunich K, Lee D, et al. Combined zidovudine and interferon-a therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989:111:280-287
28. Krown SE, Gold JW, Niedzwiecki D, Bundow D, Flomenberg N, Gansbacher B, et al. Interferon-a with zidovudine: safety, tolerance, and clinical and virologie effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990;112:812-821
29. Murphy M, Armstrong D, Sepkowitz KA, Ahkami RN, Myskowski PL. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor [letter]. AIDS 1997;ll:261-262
30. Rizzieri DA, Liu J, Traweek ST, Miralles GD. Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor [letter]. Lancet 1997:349:775-776
31. Huang L, Schnapp LM, Gruden JF, Hopewell PC, Stansell JD. Presentation of AIDS-related pulmonary Kaposi's sarcoma diagnosed by bronchoscopy. Am J Respir Crit Care Med 1996:153:1385-1390
32. Irwin DH, Kaplan LD. Pulmonary manifestations of acquired immunodeficiency syndrome-associated malignancies. Semin Respir Infect 1993:8:139-148
33. Cadranel JL, Kammoun S, Chevret S, Parrot A, Denis M, Winter C, et al. Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax 1994:49:958-960
34. Denton AS, Miller RF, Spittle MF. Management of pulmonary Kaposi's sarcoma: new perspectives. Br J Hosp Med 1995:53:344350
35. Gill PS, Wernz J, Myers A, Scadden D, Espina B, Mukwaya G, et al. Liposomal encapsulated daunorubicin (DaunoXome) in AIDS-related pulmonary Kaposi's sarcoma [abstract]. Proc Annu Meet Am Soc Clin Oncol 1997;16:A189
36. Doyle M, Johnstone PA, Watkins EB, Role of radiation therapy in management of pulmonary Kaposi's sarcoma. South Med J 1993:86:285-288
37. Centers for Disease Control and Prevention. Update: trends in AIDS incidence, deaths, and prevalence-United States, 1996. MMWR Morb Mortal Wkly Rep 1997:46:165-173
38. loannidis JP, Sacks HS, Cappelleri JC, Lau J. Clinical efficacy of antiretroviral changes in treatment-experienced HIV-infected patients: a meta-analysis [abstract]. 4th Conf Retroviruses Opportun Infect 1997;4:168
39. Miles SA, Wang H, Elashoff R, Mitsuyasu RT. Improved survival for patients with AIDS-related Kaposi's sarcoma. J Clin Oncol 1994; 12:1910-1916
40. Kempf D, Molla A, Sun E, Danner S, Boucher C, Leonard J. The duration of viral suppression is predicted by viral load during protease inhibitor therapy [abstract]. 4th Conf Retroviruses Opportun Infect 1997;4:176
41. Connors M, Kovacs JA, Krevat S, Gea-Banacloche JC, Sneller MC, Flanigan M, et al. HIV infection induces changes in CD4 T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997:3:533-540